IN2013CN07459A - - Google Patents

Info

Publication number
IN2013CN07459A
IN2013CN07459A IN7459CHN2013A IN2013CN07459A IN 2013CN07459 A IN2013CN07459 A IN 2013CN07459A IN 7459CHN2013 A IN7459CHN2013 A IN 7459CHN2013A IN 2013CN07459 A IN2013CN07459 A IN 2013CN07459A
Authority
IN
India
Prior art keywords
mycoplasmas
streptococci
formula
compound represented
effective against
Prior art date
Application number
Other languages
English (en)
Inventor
Tomohiro Sugimoto
Naoki Sasamoto
Jun Kurosaka
Masato Hayashi
Kanako Yamamoto
Masato Kashimura
Yasunobu Ushiki
Haruhisa Ogita
Tomoaki Miura
Kenichi Kanemoto
Kou Kumura
Satoshi Yoshida
Keiji Tamura
Eiki Shitara
Original Assignee
Taisho Pharmaceutical Co Ltd
Meiji Seika Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46721028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2013CN07459(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Taisho Pharmaceutical Co Ltd, Meiji Seika Pharma Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of IN2013CN07459A publication Critical patent/IN2013CN07459A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IN7459CHN2013 2011-02-21 2012-02-20 IN2013CN07459A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011034578 2011-02-21
PCT/JP2012/054677 WO2012115256A1 (en) 2011-02-21 2012-02-20 C-4" position substituted macrolide derivative

Publications (1)

Publication Number Publication Date
IN2013CN07459A true IN2013CN07459A (he) 2015-04-24

Family

ID=46721028

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7459CHN2013 IN2013CN07459A (he) 2011-02-21 2012-02-20

Country Status (35)

Country Link
US (1) US9139609B2 (he)
EP (1) EP2678349B1 (he)
JP (1) JP5687777B2 (he)
KR (1) KR20140008388A (he)
CN (1) CN103492404B (he)
AR (1) AR085286A1 (he)
AU (1) AU2012222267B2 (he)
BR (1) BR112013020118A2 (he)
CA (1) CA2827474A1 (he)
CL (1) CL2013002313A1 (he)
CO (1) CO6801737A2 (he)
CY (1) CY1117381T1 (he)
DK (1) DK2678349T3 (he)
ES (1) ES2566368T3 (he)
HR (1) HRP20160252T1 (he)
HU (1) HUE028245T2 (he)
IL (1) IL227663A (he)
IN (1) IN2013CN07459A (he)
ME (1) ME02475B (he)
MX (1) MX2013009585A (he)
MY (1) MY161451A (he)
NZ (1) NZ613956A (he)
PE (1) PE20140649A1 (he)
PH (1) PH12013501695B1 (he)
PL (1) PL2678349T3 (he)
RS (1) RS54635B1 (he)
RU (1) RU2599718C2 (he)
SA (1) SA112330287B1 (he)
SG (1) SG192655A1 (he)
SI (1) SI2678349T1 (he)
SM (1) SMT201600106B (he)
TW (1) TWI513704B (he)
UA (1) UA111191C2 (he)
WO (1) WO2012115256A1 (he)
ZA (1) ZA201305983B (he)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 Ｃ−４”位置換マクロライド誘導体を含有する医薬
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103588833B (zh) * 2013-10-30 2016-08-17 北京科技大学 动物抗菌素泰拉霉素的制备方法
CN109748942A (zh) * 2014-05-16 2019-05-14 普莱柯生物工程股份有限公司 一种大环内酯类化合物
AR102810A1 (es) * 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
WO2017142002A1 (ja) * 2016-02-17 2017-08-24 大正製薬株式会社 Ｃ－４"位置換マクロライド化合物フリー体及び塩の結晶形並びにそれらの製造方法
CN108610388B (zh) * 2016-12-12 2020-11-06 浙江京新药业股份有限公司 一种大环内酯的制备方法
CN109425666B (zh) * 2017-08-28 2022-07-08 广东东阳光药业有限公司 一种酰氯衍生物的lc-ms分析方法
AU2019339777B2 (en) 2018-09-12 2022-09-01 Novartis Ag Antiviral pyridopyrazinedione compounds
AU2020353055B2 (en) 2019-09-26 2024-03-07 Gilead Sciences, Inc. Antiviral pyrazolopyridinone compounds
CN111423482B (zh) * 2020-04-26 2023-01-17 梯尔希（南京）药物研发有限公司 一种同位素标记的红霉胺的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US5393743A (en) 1993-07-06 1995-02-28 Abbott Laboratories Erythromycin derivatives
FR2719587B1 (fr) 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
RU2144541C1 (ru) * 1995-12-08 2000-01-20 Руссель Юклаф Производные эритромицина, способ их получения, промежуточный продукт, фармацевтическая композиция
DE69733723T2 (de) 1996-09-04 2006-04-20 Abbott Laboratories, Abbott Park 6-o-Substituierte Ketoliden mit antibakteriellen Wirkung
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US5804565A (en) 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
HN1998000074A (es) 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6407074B1 (en) 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
US5972898A (en) * 1998-03-27 1999-10-26 Abbott Laboratories 3',3-N-bis-substituted macrolide LHRH antagonists
EA200100983A1 (ru) 1999-05-24 2002-10-31 Пфайзер Продактс Инк. Производные 13-метилэритромицина
UY26964A1 (es) 2000-10-16 2002-06-20 Abbott Lab Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal
WO2008106224A1 (en) * 2007-02-28 2008-09-04 Rib-X Pharmaceuticals, Inc. Macrolide compounds and methods of making and using the same
US20080203485A1 (en) 2007-02-28 2008-08-28 International Business Machines Corporation Strained metal gate structure for cmos devices with improved channel mobility and methods of forming the same

Also Published As

Publication number Publication date
RU2013142898A (ru) 2015-03-27
AR085286A1 (es) 2013-09-18
TW201247693A (en) 2012-12-01
SMT201600106B (it) 2016-04-29
AU2012222267B2 (en) 2016-07-07
RU2599718C2 (ru) 2016-10-10
JP5687777B2 (ja) 2015-03-18
AU2012222267A1 (en) 2013-08-22
JP2014505723A (ja) 2014-03-06
UA111191C2 (uk) 2016-04-11
ZA201305983B (en) 2014-11-26
TWI513704B (zh) 2015-12-21
RS54635B1 (sr) 2016-08-31
CO6801737A2 (es) 2013-11-29
DK2678349T3 (en) 2016-03-07
HUE028245T2 (en) 2016-12-28
PE20140649A1 (es) 2014-06-25
CL2013002313A1 (es) 2014-08-08
SG192655A1 (en) 2013-09-30
IL227663A (he) 2017-09-28
EP2678349A1 (en) 2014-01-01
EP2678349A4 (en) 2014-07-30
ES2566368T3 (es) 2016-04-12
ME02475B (me) 2017-02-20
IL227663A0 (he) 2013-09-30
MY161451A (en) 2017-04-14
PL2678349T3 (pl) 2016-06-30
SI2678349T1 (sl) 2016-04-29
BR112013020118A2 (pt) 2017-07-18
US20140046043A1 (en) 2014-02-13
EP2678349B1 (en) 2016-01-13
MX2013009585A (es) 2014-06-05
CY1117381T1 (el) 2017-04-26
KR20140008388A (ko) 2014-01-21
SA112330287B1 (ar) 2015-10-11
CN103492404A (zh) 2014-01-01
WO2012115256A1 (en) 2012-08-30
CA2827474A1 (en) 2012-08-30
PH12013501695A1 (en) 2013-10-07
CN103492404B (zh) 2016-09-07
HRP20160252T1 (hr) 2016-04-22
NZ613956A (en) 2014-07-25
PH12013501695B1 (en) 2018-07-11
US9139609B2 (en) 2015-09-22

Similar Documents

Publication Publication Date Title
IN2013CN07459A (he)
MY163187A (en) Novel imidazo-oxazine compound or salt thereof
GB2491139B (en) Channel access control
EP2875029B8 (en) 5,5-heteroaromatic anti-infective compounds
HUE043529T2 (hu) Átviteli idõintervallum (TTI) kötegelés fizikai letöltés irányú kapcsolati megosztott csatornához (PDSCH)
SI2694508T1 (sl) Soli substituiranega 2,3-dihidroimidazo(1,2-C)kinazolina
EP2968384A4 (en) Convergent processes for preparing macrolide antibacterial agents
SG10201507032YA (en) Benzoxaborole derivatives for treating bacterial infections
ZA201306375B (en) Multiple portal guide
PH12016502357A1 (en) Polyene macrolide derivative
MX357987B (es) Sistema de guia para puerta deslizante.
EP2763609A4 (en) OPTIMIZED PNEUMATIC DRIVE LINES
SG11201401710PA (en) 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives
MX366983B (es) Derivados de 1,5-naftiridina e inhibidores de cinasa de cremallallera de leucina embrionica materna que los contienen.
IL227975A0 (he) 4–אריל–n–פניל–5,3,1 – טריאזין –2–אמינים מותמרים
MY158171A (en) Control device for information processing device
EP3037428A4 (en) Macrolide compound
PL3077521T3 (pl) Nowy system do zmiany genomu dla mikroorganizmów
HUP1100495A2 (en) Synergistic biocontrol compounds against xanthomonas infections
PT2594580T (pt) Método para diagnóstico de infecções por bactérias propionibacterium
PL2935725T3 (pl) Usprawniony regulacyjny układ do murarskiej prowadnicy
PT3027587T (pt) Compostos de ciclobutilo 1,2-dissubstituídos
EP2701921A4 (en) MAGNETIC SHEET SYSTEMS WITH ENHANCED RIGIDITY
IT1399574B1 (it) Dispositivo di apertura, particolarmente per un elettrodomestico incassato.
UA87695U (uk) Сполука 4,5,6,7-тетрагідро-3н-2-n-(пара-метоксифенациламіно)-азепіну гідрохлорид, що має інотропну активність